Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution
Annals of Hematology · 09.05.2026 · 105 (7)
DOI: 10.1007/s00277-026-07061-6 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 09.05.2026. Verfasst von Fumihiko Nakao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Aniline Compounds, Pyrazines, Leukemia, Myeloid, Acute. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: a Grant-in-Aid for Early-Career Scientists from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science, he Shin-nihon Foundation of Advanced Medical Treatment Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
- Department of Hematology, Kyushu Medical Center, Fukuoka, Japan.
- Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan. shima@fukuoka-u.ac.jp.
- Division of Precision Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Förderung
- a Grant-in-Aid for Early-Career Scientists from the Japan Society for the Promotion of Science
- a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science
- he Shin-nihon Foundation of Advanced Medical Treatment Research
- he Kaibara Morikazu Medical Science Promotion Foundation
Zitieren
APA
Nakao, F., Shima, T., Takigawa, K., Semba, Y., Jinnouchi, F., Yamauchi, T., Odawara, J., Kikushige, Y., Mori, Y., Kato, K., Maeda, T., & Akashi, K. (2026). Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution. Annals of Hematology, 105(7). https://doi.org/10.1007/s00277-026-07061-6
Vancouver
Nakao F, Shima T, Takigawa K, Semba Y, Jinnouchi F, Yamauchi T, et al. Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution. Annals of Hematology. 2026;105(7). doi:10.1007/s00277-026-07061-6
BibTeX
@article{Nakao2026,
author = {Nakao, Fumihiko and Shima, Takahiro and Takigawa, Ken and Semba, Yuichiro and Jinnouchi, Fumiaki and Yamauchi, Takuji and Odawara, Jun and Kikushige, Yoshikane and Mori, Yasuo and Kato, Koji and Maeda, Takahiro and Akashi, Koichi},
title = {Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {7},
doi = {10.1007/s00277-026-07061-6}
}
EUVIMED